Please login to the form below

Not currently logged in
Email:
Password:

emotive appoints new medical director

Dr Gill Boucher joins the agency from QuintilesIMS

emotive Dr Gill Boucheremotive has appointed Dr Gill Boucher as its new medical director in a role that also sees her join the London-based agency’s senior leadership team.

Dr Boucher arrives at emotive from QuintilesIMS, where she spent seven years, most recently working as product and strategy director developing medical communications.

A qualified physician, she began her career in the NHS before taking up a position with Martindale Pharmaceuticals, where she worked in medical affairs.

Chris Edmonds, emotive’s managing director, said: “Gill is a superb addition to emotive. and strengthens an extremely high calibre senior leadership team with backgrounds from HCP, agency and client-side.

“As emotive completes its transition to a fully fledged international healthcare communications agency with a strong heritage in leveraging technologies to stimulate engagement, Gill’s experience as a practicing physician and in various roles leading teams of medical directors and writers will ensure the agency continues to deliver high-quality scientific communications.“

In her new role at emotive Dr Boucher will oversee the agency’s in-house team of medical writers and provide senior strategic direction in all disciplines of medical communications.

9th March 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...